The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Uses and abuses of screening tests
Abstract
Screening tests are ubiquitous in contemporary practice, yet the principles of screening are widely misunderstood. Screening is the testing of apparently well people to find those at increased risk of having a disease or disorder. Although an earlier diagnosis generally has intuitive appeal, earlier might not always be better, or worth the cost. Four terms describe the validity of a screening test: sensitivity, specificity, and predictive value of positive and negative results. For tests with continuous variables--eg, blood glucose--sensitivity and specificity are inversely related; where the cutoff for abnormal is placed should indicate the clinical effect of wrong results. The prevalence of disease in a population affects screening test performance: in low-prevalence settings, even very good tests have poor predictive value positives. Hence, knowledge of the approximate prevalence of disease is a prerequisite to interpreting screening test results. Tests are often done in sequence, as is true for syphilis and HIV-1 infection. Lead-time and length biases distort the apparent value of screening programmes; randomised controlled trials are the only way to avoid these biases. Screening can improve health; strong indirect evidence links cervical cytology programmes to declines in cervical cancer mortality. However, inappropriate application or interpretation of screening tests can rob people of their perceived health, initiate harmful diagnostic testing, and squander health-care…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Individual-level interpretation of diagnostic test results requires knowledge of disease prevalence in relation to clinical presentation (clinical pretest probability).”
From Diagnosis of Alzheimer's disease using plasma biomarkers adjusted to clinical probability (2024) · cites this paper as [11]
In the citing paper
“However, sensitivity and specificity provide limited information when making decisions about individual patients11–13.”
From Diagnosis of Alzheimer's disease using plasma biomarkers adjusted to clinical probability (2024) · cites this paper as [11]
In the citing paper
“In contrast, predictive values are critical for interpreting individual-level test results11,12,14,15.”
From Diagnosis of Alzheimer's disease using plasma biomarkers adjusted to clinical probability (2024) · cites this paper as [11]
In the citing paper
“Correspondingly, the PPV and NPV estimates from our study should not be extrapolated to other clinical settings where the prevalence of AD is substantially different11,12,14,15.”
From Diagnosis of Alzheimer's disease using plasma biomarkers adjusted to clinical probability (2024) · cites this paper as [11]
Citations
Cites
Clinical Epidemiology: A Basic Science for Clinical Medicine.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-825_9 · Cited by 3,476
Hennekens, C. H., Buring, J. E., & Mayrent, S. L. (1987) · Medical Entomology and Zoology · Cited by 2,319
Guide to Clinical Preventive Services
Wesley Allen, T. (1991) · The Journal of the American Osteopathic Association · doi:10.1515/jom-1991-900515 · Cited by 2,129
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-2-316_4 · Cited by 1,926
Guide to Effective Care in Pregnancy and Childbirth
Enkin, M., Keirse, M., Neilson, J., Crowther, C., Duley, L., Hodnett, E., & Hofmeyr, J. (2000) · Oxford University Press eBooks · doi:10.1093/med/9780192631732.001.0001 · Cited by 909
Is screening for breast cancer with mammography justifiable?
Gøtzsche, P. C., & Olsen, O. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06065-1 · Cited by 853
Cochrane review on screening for breast cancer with mammography
Olsen, O., & Gøtzsche, P. C. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06449-2 · Cited by 710
Ovarian Cancer: Screening, Treatment, and Follow-up
Seltzer, V. (1995) · JAMA · doi:10.1001/jama.1995.03520300065039 · Cited by 580
Increased Absenteeism from Work after Detection and Labeling of Hypertensive Patients
Haynes, R. B., Sackett, D. L., Taylor, D. W., Gibson, E. S., & Johnson, A. L. (1978) · New England Journal of Medicine · doi:10.1056/nejm197810052991403 · Cited by 510
Biases in the assessment of diagnostic tests
Begg, C. B. (1987) · Statistics in Medicine · doi:10.1002/sim.4780060402 · Cited by 496
Cited by
Zeng, X., Zhang, Y., Kwong, J. S. W., Zhang, C., Li, S., Sun, F., Niu, Y., & Du, L. (2015) · Journal of Evidence-Based Medicine · doi:10.1111/jebm.12141 · Cited by 2,082
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Blennow, K., Hampel, H., Weiner, M., & Zetterberg, H. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.4 · Cited by 1,863
Kapur, S., Phillips, A. G., & Insel, T. R. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.105 · Cited by 980
Refining clinical diagnosis with likelihood ratios
Grimes, D. A., & Schulz, K. F. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66422-7 · Cited by 828
Self-citationScreening tests: a review with examples
Maxim, L. D., Niebo, R., & Utell, M. J. (2014) · Inhalation Toxicology · doi:10.3109/08958378.2014.955932 · Cited by 562
Metadata
- Authors
- Grimes, D. A., & Schulz, K. F.
- Affiliations
- Family Health International 360 (US)
- Corresponding author
- Grimes, David A
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2002-03
- Volume
- 359
- Issue
- 9309
- Pages
- 881-884
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2002693002
- Cited by
- 545
- References
- 26
- Citations by year
- 2026: 16 · 2025: 22 · 2024: 20 · 2023: 16 · 2022: 17 · 2021: 19 · 2020: 16 · 2019: 18 · 2018: 20 · 2017: 25 · 2016: 23 · 2015: 30 · 2014: 23 · 2013: 32 · 2012: 26
- FWCI
- 10.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- DigitalGeorgetown (Georgetown University Library) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
- Keywords
- screening test, sensitivity and specificity, predictive value, disease prevalence, lead-time bias, length bias, cervical cancer screening, cervical cytology, syphilis screening, cost-effectiveness of screening, overdiagnosis, randomized controlled trials
- MeSH terms
- Ethics, Medical, False Negative Reactions, False Positive Reactions, Female, Humans, Infant, Newborn, Male, Mass Screening, Middle Aged, Predictive Value of Tests, Pregnancy, Sensitivity and Specificity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Uses and abuses of screening tests. https://app.cochat.ai/papers/10.1016/s0140-6736(02)07948-5
- The paper
- Grimes, D. A., & Schulz, K. F. (2002). Uses and abuses of screening tests. The Lancet. https://doi.org/10.1016/s0140-6736(02)07948-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.